Cargando…

Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?

Over the last decades, vaccine development has advanced significantly in pursuing higher safety with less side effects. However, this is often accompanied by a reduction in vaccine immunogenicity and an increased dependency on adjuvants to enhance vaccine potency. Especially for diseases like cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, Nataschja I., Huis in 't Veld, Lisa G. M., Raaijmakers, Tonke K., Adema, Gosse J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300500/ https://www.ncbi.nlm.nih.gov/pubmed/30619259 http://dx.doi.org/10.3389/fimmu.2018.02874

Ejemplares similares

Saponin-based adjuvant-induced dendritic cell cross-presentation is dependent on PERK activation
por: Huis in ’t Veld, Lisa G. M., et al.
Publicado: (2022)

Saponin-based adjuvants enhance antigen cross-presentation in human CD11c(+) CD1c(+) CD5(−) CD163(+) conventional type 2 dendritic cells
por: Ho, Nataschja I, et al.
Publicado: (2023)

Mechanical high-intensity focused ultrasound creates unique tumor debris enhancing dendritic cell-induced T cell activation
por: van den Bijgaart, Renske J. E., et al.
Publicado: (2022)

NSAIDs affect dendritic cell cytokine production
por: Raaijmakers, Tonke K., et al.
Publicado: (2022)

Tumor ablation plus co-administration of CpG and saponin adjuvants affects IL-1 production and multifunctional T cell numbers in tumor draining lymph nodes
por: Raaijmakers, Tonke K, et al.
Publicado: (2020)

Microenvironmental derived factors modulating dendritic cell function and vaccine efficacy: the effect of prostanoid receptor and nuclear receptor ligands
por: Raaijmakers, Tonke K., et al.
Publicado: (2018)

Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation
por: den Brok, Martijn H., et al.
Publicado: (2016)

Vaccine adjuvants to engage the cross-presentation pathway
por: Lee, Woojong, et al.
Publicado: (2022)

Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ
por: van den Bijgaart, Renske J. E., et al.
Publicado: (2021)

Autophagy regulates long‐term cross‐presentation by murine dendritic cells
por: Ho, Nataschja I., et al.
Publicado: (2021)

Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform
por: Pérez, Oliver, et al.
Publicado: (2013)

Sustained cross‐presentation capacity of murine splenic dendritic cell subsets in vivo
por: Ho, Nataschja I., et al.
Publicado: (2018)

Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21
por: Welsby, Iain, et al.
Publicado: (2017)

Dendritic cell-based vaccine prepared with recombinant Lactococcus lactis enhances antigen cross-presentation and antitumor efficacy through ROS production
por: Zhang, Tingting, et al.
Publicado: (2023)

Glycan modification of antigen alters its intracellular routing in dendritic cells, promoting priming of T cells
por: Streng-Ouwehand, Ingeborg, et al.
Publicado: (2016)

Siglec Signaling in the Tumor Microenvironment
por: van Houtum, Eline J. H., et al.
Publicado: (2021)

Distinct antigen uptake receptors route to the same storage compartments for cross‐presentation in dendritic cells
por: Ho, Nataschja I., et al.
Publicado: (2021)

Dendritic Cells Actively Limit Interleukin-10 Production Under Inflammatory Conditions via DC-SCRIPT and Dual-Specificity Phosphatase 4
por: Søndergaard, Jonas Nørskov, et al.
Publicado: (2018)

Adjuvants for Coronavirus Vaccines
por: Liang, Zhihui, et al.
Publicado: (2020)

Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10
por: Llopiz, Diana, et al.
Publicado: (2018)

Toll-Like Receptor Ligand Based Adjuvant, PorB, Increases Antigen Deposition on Germinal Center Follicular Dendritic Cells While Enhancing the Follicular Dendritic Cells Network
por: Lisk, Christina, et al.
Publicado: (2020)

A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8(+) T Cells
por: Matsuo, Kazuhiko, et al.
Publicado: (2018)

Vaccine Adjuvant Informatics: From Data Integration and Analysis to Rational Vaccine Adjuvant Design
por: He, Yongqun
Publicado: (2014)

Dendritic Cells in the Cross Hair for the Generation of Tailored Vaccines
por: Gornati, Laura, et al.
Publicado: (2018)

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
por: Repáraz, David, et al.
Publicado: (2022)

Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy
por: Zimmermann, Jennifer, et al.
Publicado: (2022)

Retrospective analysis on the immunopotentiating mechanism of an emulsion-based vaccine adjuvant on human antigen presenting cells
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2023)

Regulatory dendritic cells: there is more than just immune activation
por: Schmidt, Susanne V., et al.
Publicado: (2012)

Vaccine Adjuvants: Mode of Action
por: De Gregorio, Ennio, et al.
Publicado: (2013)

Dendritic Cell-Targeted Vaccines
por: Cohn, Lillian, et al.
Publicado: (2014)

DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination
por: Hayashi, Tomoya, et al.
Publicado: (2018)

An Altered gp100 Peptide Ligand with Decreased Binding by TCR and CD8α Dissects T Cell Cytotoxicity from Production of Cytokines and Activation of NFAT
por: Schaft, Niels, et al.
Publicado: (2013)

Small Molecule NF-κB Inhibitors as Immune Potentiators for Enhancement of Vaccine Adjuvants
por: Moser, Brittany A., et al.
Publicado: (2020)

Mechanism of activation of porcine dendritic cells by an α-D-glucan nanoparticle adjuvant and a nanoparticle/poly(I:C) combination adjuvant
por: Hernandez-Franco, Juan F., et al.
Publicado: (2022)

Understanding the Functional Properties of Neonatal Dendritic Cells: A Doorway to Enhance Vaccine Effectiveness?
por: Papaioannou, Nikos E., et al.
Publicado: (2019)

Self-Antigen Presentation by Dendritic Cells in Autoimmunity
por: Hopp, Ann-Katrin, et al.
Publicado: (2014)

Cancer Vaccines, Adjuvants, and Delivery Systems
por: Paston, Samantha J., et al.
Publicado: (2021)

Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings
por: Vázquez-Maldonado, Nancy, et al.
Publicado: (2023)

Cross-Presentation of Cell-Associated Antigens by Mouse Splenic Dendritic Cell Populations
por: Thacker, Robert I., et al.
Publicado: (2012)

Dendritic Cell Vaccines in Ovarian Cancer
por: Zhang, Xi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j5oukercg4q6873r9pvkl3gr5e